{"entity":{"id":"nct06828991","kind":"trial","name":"A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP","aka":[],"tldr":"A phase 2 trial of Mosunetuzumab and clonoSEQ in Diffuse large B-cell lymphoma, run by Danielle Wallace, now recruiting.","summary":"A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP is a phase 2 interventional study registered as NCT06828991 by Danielle Wallace, with 40 participants planned, started 2025-09-04 and due to reach its primary completion in 2029-04-01. Interventions recorded: Mosunetuzumab, ClonoSEQ. Conditions recorded: Diffuse Large B-Cell Lymphoma (DLBCL).\n\nLinked to the drug clonoSEQ because the registry names it among its interventions and Diffuse large B-cell lymphoma among its conditions. Registry record only: no result has been read by an editor.","status":"recruiting","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT06828991","url":"https://clinicaltrials.gov/study/NCT06828991"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["dlbcl"],"sections":[],"technologies":[],"targets":[],"drugs":["mosunetuzumab","clonoseq"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06828991","phase":"2","setting":"ctDNA-Guided Mosunetuzumab Consolidation Therapy in Older Patients With Untreated DLBCL","sponsor":"Danielle Wallace","participation":[{"nct":"NCT06828991","source":"https://clinicaltrials.gov/study/NCT06828991","fetchedAt":"2026-10-07T16:55:06.589Z","studySha256":"1122eae5c0619cde33f7da9091395112f92e631254ca94d123e3dbbc744f2069","overallStatus":"RECRUITING","lastUpdatePosted":"2025-10-20","leadSponsor":"Danielle Wallace","collaboratorCount":3,"minimumAge":"70 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":40,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["United States"]}],"started":"2025-09-04","startedType":"actual","enrolled":40,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06828991/","neighbours":{"cancer":[{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"}],"drug":[{"id":"clonoseq","kind":"drug","name":"clonoSEQ","route":"/drugs/clonoseq/"},{"id":"mosunetuzumab","kind":"drug","name":"Mosunetuzumab","route":"/drugs/mosunetuzumab/"}]}}